Be part of the knowledge.™

Pediatrics

390

LikeLikedUnlike

16-26 of 26

Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
MinuteCE®
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
- Anne M. Morse, DO
1.00 program credits
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
MinuteCE®
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
- Funke Afolabi-Brown, MD
1.00 program credits
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
MinuteCE®
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
- Anne M. Morse, DO
1.00 program credits
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CE
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
- Omer Abdul Hamid, MD
- Nancy Kuntz, MD
- Migvis Monduy, MD
0.25 credits
MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 credits 4 episodes
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
advertisement
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
- Danielle Becker, MD, MS, FAES
- Ahmed Abdelmoity, MD
- Deborah Holder, MD
- John Stern, MD
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
CME/CE
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
- William Mencia, MD, FACEHP
- Julie Blatt, MD
- Taizo Nakano, MD
0.50 credits
advertisement

Program Chapters

Segment Chapters

Playlist:

Recommended